<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-biomolecules-09-00138" class="ref">
 <label class="label">42.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Qadri</surname>
    <given-names class="given-names">G.R.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ahad</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Aqil</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Imam</surname>
    <given-names class="given-names">S.S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ali</surname>
    <given-names class="given-names">A.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Invasomes of isradipine for enhanced transdermal delivery against hypertension: Formulation, characterization, and in vivo pharmacodynamic study</article-title>
  <source class="source">Artif. Cells Nanomed. Biotechnol.</source>
  <year class="year">2017</year>
  <volume class="volume">45</volume>
  <fpage class="fpage">139</fpage>
  <lpage class="lpage">145</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.3109/21691401.2016.1138486</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">26829018</pub-id>
 </element-citation>
</ref>
